Given the current 42% US obesity rate and powerful results from the new anti-obesity medications (AOMs), employers and others responsible for healthcare benefits decisions are feeling pressure to add coverage for these expensive AOMs to employee health benefits plans. However, with a recent study showing 65% weight regain after patients stop taking their AOM meds, …
There is an intense media focus on the arrival of a new class of Anti Obesity Medications (AOMs) and a robust national discussion to clarify their value (“bang for the buck”) given the mix of positives (significant clinical benefits) and negatives (side effects, weight regain on stopping, and high price tag). This is the first …
Dr. Garry Welch, Co-Founder and Chief Scientific Officer of Silver Fern Healthcare, was recently invited to speak about his expertise in chronic disease management on “The Public Health Podcast.” The podcast is produced by a team of NPR veterans and is hosted by Ryan Birchmeier and Katie Fendler, a brother-sister duo that is “bringing the public back into public …
